The regulatory network governing ER-induced RET expression in breast cancer models has been well-described with multiple estrogen response elements (EREs) identified within the RET enhancer region (where multiple databases note the presence of ER binding sites, reviewed in detail by Wang et al. [60]). The gene discussed is ESR1; the disease is breast carcinoma.